No Data
No Data
Express News | Tenaya Therapeutics Inc : William Blair Initiates Coverage With Outperform Rating
William Blair Initiates Tenaya Therapeutics(TNYA.US) With Buy Rating
William Blair analyst Sami Corwin initiates coverage on $Tenaya Therapeutics(TNYA.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 43.9% and a total average return
William Blair Starts Tenaya Therapeutics With Outperform Rating
Tenaya Therapeutics (TNYA) has an average rating of buy and price targets ranging from $7 to $40, according to analysts polled by Capital IQ.
We're Keeping An Eye On Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate
TD Cowen Keeps Their Buy Rating on Tenaya Therapeutics (TNYA)
Canaccord Genuity Adjusts Tenaya Therapeutics Price Target to $16 From $18, Maintains Buy Rating
Tenaya Therapeutics (TNYA) has an average rating of buy and price targets ranging from $7 to $40, according to analysts polled by Capital IQ. Price: 4.26, Change: +0.01, Percent Change: +0.24